MM 54

This potent apelin receptor antagonist exhibits high affinity (Ki = 82 nM) and effectively blocks apelin-13-mediated signaling in vitro. It has demonstrated efficacy in preclinical cancer research, significantly reducing tumor growth and improving survival in a mouse glioblastoma xenograft model.